|
SRC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.327600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.361600E-01 |
| Normal-vs-Stage2 |
6.197700E-02 |
| Normal-vs-Stage3 |
1.289780E-01 |
| Normal-vs-Stage4 |
9.173600E-04 |
| Stage1-vs-Stage2 |
9.108200E-02 |
| Stage1-vs-Stage3 |
4.375900E-02 |
| Stage1-vs-Stage4 |
1.249110E-04 |
| Stage2-vs-Stage3 |
2.416500E-03 |
| Stage2-vs-Stage4 |
3.73180000001749E-06 |
| Stage3-vs-Stage4 |
2.856400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.146400E-01 |
| Normal-vs-AfricanAmerican |
1.225900E-02 |
| Normal-vs-Asian |
1.537590E-01 |
| Caucasian-vs-AfricanAmerican |
9.157200E-03 |
| Caucasian-vs-Asian |
5.218100E-02 |
| AfricanAmerican-vs-Asian |
6.582000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.856560E-01 |
| Normal-vs-Female |
2.229700E-04 |
| Male-vs-Female |
6.38240005290669E-09 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.494600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.654200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.553400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.337400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.179200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.317000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.571400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.030600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.218800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.998200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.532620E-01 |
| Normal-vs-Grade 2 |
3.459200E-01 |
| Normal-vs-Grade 3 |
3.100000E-01 |
| Normal-vs-Grade 4 |
1.082180E-03 |
| Grade 1-vs-Grade 2 |
9.812100E-02 |
| Grade 1-vs-Grade 3 |
5.422400E-01 |
| Grade 1-vs-Grade 4 |
5.321000E-01 |
| Grade 2-vs-Grade 3 |
3.192300E-02 |
| Grade 2-vs-Grade 4 |
3.67490000000581E-05 |
| Grade 3-vs-Grade 4 |
1.181720E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.232230E-01 |
| Normal-vs-ccB subtype |
4.115800E-01 |
| ccA subtype-vs-ccB subtype |
1.163880E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.548000E-01 |
| Normal-vs-N1 |
1.67722999999675E-05 |
| N0-vs-N1 |
6.961800E-03 |
|
|
